Edmp, Inc. Q2 2023 vs. Q3 2023 13F Holdings Comparison

---

The Evolution of Edmp, Inc.'s Investment Holdings: Q2 2023 vs. Q3 2023

Edmp, Inc., a prominent investment company, recently released its 13F Holdings Comparison for the second and third quarters of 2023. This report provides a comprehensive overview of the changes in holdings for various companies during this period. In this article, we will delve into the key insights from the data, highlighting significant increases and decreases in holdings.

One notable change in Edmp, Inc.'s portfolio is their reduced investment in Broadcom Inc., a global technology leader. While the company still holds a significant position, their holdings decreased by 9.4% in Q3 2023. This reduction could indicate a shift in investment strategy or a reevaluation of the company's performance.

On the other hand, Edmp, Inc. increased their holdings in healthcare giant Amgen Inc. by 24.5% during the same period. This suggests a positive outlook on the company's prospects and future growth potential. Amgen Inc.'s stock has been performing well, making it an attractive investment opportunity for Edmp, Inc.

Omega Healthcare Investors Inc., a real estate investment trust specializing in healthcare-related properties, also experienced a slight decrease in holdings by 6.3%. This change could be due to various factors, including market conditions or specific developments within the company.

Among the top holdings, AbbVie Inc., the pharmaceutical company known for brands such as Humira, saw a modest increase in holdings by 2.2%. This reaffirms Edmp, Inc.'s confidence in AbbVie's long-term growth prospects and their position within the healthcare industry.

However, Altria Group Inc., a leading tobacco company, faced a decrease in holdings by 8.8%. This decline could be attributed to several factors, including increased regulations and changing consumer preferences. It will be interesting to see how Edmp, Inc. navigates these challenges in the future.

Moving forward, Edmp, Inc. also demonstrated their belief in AFLAC Inc., a major insurance provider, by increasing their holdings by 4.5%. This suggests that the company has a positive outlook on the insurance industry and believes in AFLAC Inc.'s ability to generate stable returns.

Skyworks Solutions Inc., a global semiconductor company, experienced a decrease in holdings by 13.7% in Q3 2023. This change might reflect Edmp, Inc.'s assessment of the company's growth potential in light of market dynamics and competitive challenges.

Furthermore, CVS Health Corp, the well-known pharmacy and healthcare company, witnessed a decrease in holdings by 3.3%. This change could be a result of various factors, including industry dynamics and the company's financial performance during the period.

Among the notable increases in holdings, Ameriprise Financial Inc. witnessed a notable surge of 17.7% in Edmp, Inc.'s portfolio. This indicates Edmp, Inc.'s confidence in the financial services industry and Ameriprise Financial Inc.'s ability to deliver strong results.

Lastly, we observed a significant decrease in holdings for Johnson & Johnson by 41.5%. This change could be influenced by various factors, including regulatory concerns and product-related issues. It will be interesting to monitor how Edmp, Inc. approaches their investment strategy for the pharmaceutical giant.

In conclusion, Edmp, Inc.'s 13F Holdings Comparison for Q2 2023 and Q3 2023 reveals interesting trends in their investment portfolio. While some companies experienced increases in holdings, others faced reductions. These changes reflect Edmp, Inc.'s strategic decisions and their assessment of each company's current and future prospects. As with any investment portfolio, these holdings are subject to market volatility and can change over time. It will be intriguing to see how Edmp, Inc.'s investment strategy continues to evolve in the coming quarters, and how these changes will ultimately shape their overall portfolio performance.